Wednesday, April 17, 2024
Insightec, a global healthcare company renowned for its dedication to utilizing acoustic energy to revolutionize patient care, has introduced Exablate Prime in Europe following its CE approval. This advancement represents a culmination of more than ten years of intensive research and development, shaped significantly by the invaluable feedback received from customers and clinicians.
Exablate Prime is specifically engineered to elevate the precision, efficiency, and overall surgical experience for both surgeons and patients, particularly in the field of neurosurgery. Offering non-invasive treatment options for conditions like essential tremor and Parkinson's disease, this platform introduces several notable enhancements:
Intuitive User Interface: Streamlined with guided workflows for simplified navigation.
Automated Calculations: Incorporating intelligent algorithms for rapid skull-density-ratio (SDR) calculations and efficient no-pass region detection.
Enhanced Therapy Delivery: Utilizing accurate temperature prediction algorithms to ensure precise control during treatment.
Increased Specificity and Control: Providing sub-millimetric targeting control and advanced shaping masks for meticulous lesion shaping.
Real-Time Monitoring: Offering cumulative thermal dose overlays to enhance treatment safety.
Enhanced Planning & Support: Improvements in cybersecurity, PACS connectivity, and remote planning for enhanced operational efficiency.
Improved Visualization and Image Management: Introducing automated MR scan acquisition and intelligent targeting tools to optimize surgical planning and execution.
Prior to its European launch, Exablate Prime underwent rigorous testing at renowned medical institutions such as Rambam Hospital in Haifa, Israel, and Oregon Health and Science University in the US. Feedback from these testing phases was instrumental in refining the platform to meet the rigorous standards of working neurosurgeons. This introduction marks a significant milestone in advancing neurosurgical capabilities, offering renewed hope for improved patient outcomes across Europe.
Source: prnewswire.com
